169 related articles for article (PubMed ID: 32940116)
1. The value of p16 and HPV DNA in non-tonsillar, non-base of tongue oropharyngeal cancer.
Hammarstedt L; Holzhauser S; Zupancic M; Kapoulitsa F; Ursu RG; Ramqvist T; Haeggblom L; Näsman A; Dalianis T; Marklund L
Acta Otolaryngol; 2021 Jan; 141(1):89-94. PubMed ID: 32940116
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of cell cycle-associated proteins p16, pRB, cyclin D1 and p53 in resected oropharyngeal carcinoma.
Plath M; Broglie MA; Förbs D; Stoeckli SJ; Jochum W
J Otolaryngol Head Neck Surg; 2018 Sep; 47(1):53. PubMed ID: 30189895
[TBL] [Abstract][Full Text] [Related]
3. Double positivity for HPV DNA/p16 in tonsillar and base of tongue cancer improves prognostication: Insights from a large population-based study.
Garnaes E; Frederiksen K; Kiss K; Andersen L; Therkildsen MH; Franzmann MB; Specht L; Andersen E; Norrild B; Kjaer SK; von Buchwald C
Int J Cancer; 2016 Dec; 139(11):2598-605. PubMed ID: 27537425
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus (HPV) load is higher in HPVDNA/p16 positive than in HPVDNA positive/p16 negative oropharyngeal squamous cell carcinoma but does not differ significantly between various subsites or correlate to survival.
Zupancic M; Kostopoulou ON; Holzhauser S; Lukoseviciute M; Jylhä C; Marklund L; Näsman A; Sivars L; Dalianis T
Oral Oncol; 2024 Apr; 151():106749. PubMed ID: 38461771
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus DNA and p16 expression in Japanese patients with oropharyngeal squamous cell carcinoma.
Kawakami H; Okamoto I; Terao K; Sakai K; Suzuki M; Ueda S; Tanaka K; Kuwata K; Morita Y; Ono K; Nishio K; Nishimura Y; Doi K; Nakagawa K
Cancer Med; 2013 Dec; 2(6):933-41. PubMed ID: 24403267
[TBL] [Abstract][Full Text] [Related]
6. Time to change perspectives on HPV in oropharyngeal cancer. A systematic review of HPV prevalence per oropharyngeal sub-site the last 3 years.
Haeggblom L; Ramqvist T; Tommasino M; Dalianis T; Näsman A
Papillomavirus Res; 2017 Dec; 4():1-11. PubMed ID: 29179862
[TBL] [Abstract][Full Text] [Related]
7. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.
Oguejiofor KK; Hall JS; Mani N; Douglas C; Slevin NJ; Homer J; Hall G; West CM
Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):630-8. PubMed ID: 23916365
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testing.
Nauta IH; Rietbergen MM; van Bokhoven AAJD; Bloemena E; Lissenberg-Witte BI; Heideman DAM; Baatenburg de Jong RJ; Brakenhoff RH; Leemans CR
Ann Oncol; 2018 May; 29(5):1273-1279. PubMed ID: 29438466
[TBL] [Abstract][Full Text] [Related]
9. [Clinicopathological characteristics of HPV(+) oropharyngeal squamous cell carcinoma].
Zhao YH; Bai YP; Mao ML; Zhang H; Zhao XL; Yang DM; Wan HF; Liu HG
Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):127-131. PubMed ID: 30695865
[No Abstract] [Full Text] [Related]
10. A systematic investigation of the association between HPV and the clinicopathological parameters and prognosis of oral and oropharyngeal squamous cell carcinomas.
Wang F; Zhang H; Xue Y; Wen J; Zhou J; Yang X; Wei J
Cancer Med; 2017 May; 6(5):910-917. PubMed ID: 28378539
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas.
Rietbergen MM; Snijders PJ; Beekzada D; Braakhuis BJ; Brink A; Heideman DA; Hesselink AT; Witte BI; Bloemena E; Baatenburg-De Jong RJ; Leemans CR; Brakenhoff RH
Int J Cancer; 2014 May; 134(10):2366-72. PubMed ID: 24249631
[TBL] [Abstract][Full Text] [Related]
12. P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.
Mooren JJ; Gültekin SE; Straetmans JM; Haesevoets A; Peutz-Kootstra CJ; Huebbers CU; Dienes HP; Wieland U; Ramaekers FC; Kremer B; Speel EJ; Klussmann JP
Int J Cancer; 2014 May; 134(9):2108-17. PubMed ID: 24127203
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic accuracy of p16
Prigge ES; Arbyn M; von Knebel Doeberitz M; Reuschenbach M
Int J Cancer; 2017 Mar; 140(5):1186-1198. PubMed ID: 27859245
[TBL] [Abstract][Full Text] [Related]
14. Concurrent HPV-related oropharyngeal carcinoma in four couples.
Sathasivam HP; Bhatia R; Bradley P; Robson A; Paleri V; Cocks H; Oozeer N; Milne D; Sloan P; Robinson M
Oral Oncol; 2018 Nov; 86():33-37. PubMed ID: 30409317
[TBL] [Abstract][Full Text] [Related]
15. Increasing prevalence of human papillomavirus-positive oropharyngeal cancers among older adults.
Windon MJ; D'Souza G; Rettig EM; Westra WH; van Zante A; Wang SJ; Ryan WR; Mydlarz WK; Ha PK; Miles BA; Koch W; Gourin C; Eisele DW; Fakhry C
Cancer; 2018 Jul; 124(14):2993-2999. PubMed ID: 29710393
[TBL] [Abstract][Full Text] [Related]
16. Incidence of human papillomavirus positive tonsillar and base of tongue carcinoma: a stabilisation of an epidemic of viral induced carcinoma?
Näsman A; Nordfors C; Holzhauser S; Vlastos A; Tertipis N; Hammar U; Hammarstedt-Nordenvall L; Marklund L; Munck-Wikland E; Ramqvist T; Bottai M; Dalianis T
Eur J Cancer; 2015 Jan; 51(1):55-61. PubMed ID: 25466506
[TBL] [Abstract][Full Text] [Related]
17. Risk profiling based on p16 and HPV DNA more accurately predicts location of disease relapse in patients with oropharyngeal squamous cell carcinoma.
Rasmussen JH; Grønhøj C; Håkansson K; Friborg J; Andersen E; Lelkaitis G; Klussmann JP; Wittekindt C; Wagner S; Vogelius IR; von Buchwald C
Ann Oncol; 2019 Apr; 30(4):629-636. PubMed ID: 30657857
[TBL] [Abstract][Full Text] [Related]
18. Use of quantitative diffusion-weighted magnetic resonance imaging to predict human papilloma virus status in patients with oropharyngeal squamous cell carcinoma.
Nakahira M; Saito N; Yamaguchi H; Kuba K; Sugasawa M
Eur Arch Otorhinolaryngol; 2014 May; 271(5):1219-25. PubMed ID: 23880924
[TBL] [Abstract][Full Text] [Related]
19. Viral RNA patterns and high viral load reliably define oropharynx carcinomas with active HPV16 involvement.
Holzinger D; Schmitt M; Dyckhoff G; Benner A; Pawlita M; Bosch FX
Cancer Res; 2012 Oct; 72(19):4993-5003. PubMed ID: 22991302
[TBL] [Abstract][Full Text] [Related]
20. Risk stratification of early stage oral tongue cancers based on HPV status and p16 immunoexpression.
Ramshankar V; Soundara VT; Shyamsundar V; Ramani P; Krishnamurthy A
Asian Pac J Cancer Prev; 2014; 15(19):8351-9. PubMed ID: 25339028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]